WHITEHAWK THERAPEUTICS, INC. Increase (Decrease) in Interest Payable, Net
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Increase (Decrease) in Interest Payable, Net of $9.94 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2017-03-07
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2016-06-30 was $2.54K, a 17.24% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2016-03-31 was $2.39K, a 29.20% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2015-12-31 was $2.22K, a 17.35% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2015-09-30 was $2.19K, a 31.87% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2016 was $9.94K, a 17.88% increase from fiscal 2015.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2015 was $8.43K, a 23.54% increase from fiscal 2014.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2014 was $6.83K, a 16.16% increase from fiscal 2013.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2013 was $5.88K, a 18.15% increase from fiscal 2012.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month | Increase (Decrease) in Interest Payable, Net 49 month | Increase (Decrease) in Interest Payable, Net 52 month | Increase (Decrease) in Interest Payable, Net 55 month | Increase (Decrease) in Interest Payable, Net 58 month | Increase (Decrease) in Interest Payable, Net 62 month | Increase (Decrease) in Interest Payable, Net 64 month | Increase (Decrease) in Interest Payable, Net 67 month | Increase (Decrease) in Interest Payable, Net 70 month | Increase (Decrease) in Interest Payable, Net 73 month | Increase (Decrease) in Interest Payable, Net 76 month | Increase (Decrease) in Interest Payable, Net 79 month | Increase (Decrease) in Interest Payable, Net 82 month | Increase (Decrease) in Interest Payable, Net 85 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $9.94K 10-K · filed 2017-03-07 | ||||||||||||||||
| 2016-06-30 | $2.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $4.94K 10-Q · filed 2016-08-15 | $7.16K derived: sum of 3 quarters · filed 2017-03-07 | $9.35K derived: sum of 4 quarters · filed 2017-03-07 | |||||||||||||
| 2016-03-31 | $2.39K 10-Q · filed 2016-05-16 | $4.61K derived: sum of 2 quarters · filed 2017-03-07 | $6.81K derived: sum of 3 quarters · filed 2017-03-07 | $8.97K derived: sum of 4 quarters · filed 2017-03-07 | |||||||||||||
| 2015-12-31 | $2.22K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $4.41K derived: sum of 2 quarters · filed 2017-03-07 | $6.58K derived: sum of 3 quarters · filed 2017-03-07 | $8.43K 10-K · filed 2017-03-07 | |||||||||||||
| 2015-09-30 | $2.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $4.36K derived: sum of 2 quarters · filed 2016-08-15 | $6.21K 10-Q · filed 2015-11-13 | $8.11K derived: sum of 4 quarters · filed 2016-08-15 | |||||||||||||
| 2015-06-30 | $2.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $4.02K 10-Q · filed 2016-08-15 | $5.91K derived: sum of 3 quarters · filed 2016-08-15 | $7.58K derived: sum of 4 quarters · filed 2016-08-15 | |||||||||||||
| 2015-03-31 | $1.85K 10-Q · filed 2016-05-16 | $3.74K derived: sum of 2 quarters · filed 2016-05-16 | $5.41K derived: sum of 3 quarters · filed 2016-05-16 | $7.05K derived: sum of 4 quarters · filed 2016-05-16 | |||||||||||||
| 2014-12-31 | $1.89K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $3.55K derived: sum of 2 quarters · filed 2016-03-30 | $5.20K derived: sum of 3 quarters · filed 2016-03-30 | $6.83K 10-K · filed 2016-03-30 | $24.00K 10-K · filed 2015-02-27 | ||||||||||||
| 2014-09-30 | $1.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $3.31K derived: sum of 2 quarters · filed 2015-11-13 | $4.94K 10-Q · filed 2015-11-13 | $6.60K derived: sum of 4 quarters · filed 2015-11-13 | $22.11K 10-Q · filed 2014-11-14 | ||||||||||||
| 2014-06-30 | $1.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $3.27K 10-Q · filed 2015-08-13 | $4.94K derived: sum of 3 quarters · filed 2015-08-13 | $6.60K derived: sum of 4 quarters · filed 2015-08-13 | $20.45K 10-Q · filed 2014-08-14 | ||||||||||||
| 2014-03-31 | $1.63K 10-Q · filed 2015-05-13 | $3.29K derived: sum of 2 quarters · filed 2015-05-13 | $4.96K derived: sum of 3 quarters · filed 2015-05-13 | $6.25K derived: sum of 4 quarters · filed 2015-05-13 | $18.80K 10-Q · filed 2014-05-15 | ||||||||||||
| 2013-12-31 | $1.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $3.33K derived: sum of 2 quarters · filed 2015-02-27 | $4.62K derived: sum of 3 quarters · filed 2015-02-27 | $5.88K 10-K · filed 2015-02-27 | $17.18K 10-K · filed 2014-03-31 | ||||||||||||
| 2013-09-30 | $1.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $2.96K derived: sum of 2 quarters · filed 2014-11-14 | $4.21K 10-Q · filed 2014-11-14 | $5.50K derived: sum of 4 quarters · filed 2014-11-14 | $15.51K 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $1.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $2.55K 10-Q · filed 2014-08-14 | $3.84K derived: sum of 3 quarters · filed 2014-08-14 | $5.12K derived: sum of 4 quarters · filed 2014-08-14 | $13.85K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $1.26K 10-Q · filed 2014-05-15 | $2.54K derived: sum of 2 quarters · filed 2014-05-15 | $3.83K derived: sum of 3 quarters · filed 2014-05-15 | $5.10K derived: sum of 4 quarters · filed 2014-05-15 | $12.55K 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | $1.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.57K derived: sum of 2 quarters · filed 2014-03-31 | $3.84K derived: sum of 3 quarters · filed 2014-03-31 | $4.97K 10-K · filed 2014-03-31 | $11.30K 10-K · filed 2013-03-28 | ||||||||||||
| 2012-09-30 | $1.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $2.56K derived: sum of 2 quarters · filed 2013-11-14 | $3.69K 10-Q · filed 2013-11-14 | $4.59K derived: sum of 4 quarters · filed 2013-11-14 | $10.01K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $1.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $2.40K 10-Q · filed 2013-08-14 | $3.31K derived: sum of 3 quarters · filed 2013-08-14 | $4.22K derived: sum of 4 quarters · filed 2013-08-14 | $8.73K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $1.13K 10-Q · filed 2013-05-15 | $2.04K derived: sum of 2 quarters · filed 2013-05-15 | $2.95K derived: sum of 3 quarters · filed 2013-05-15 | $3.84K derived: sum of 4 quarters · filed 2013-05-15 | $7.46K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $907.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.81K derived: sum of 2 quarters · filed 2013-03-28 | $2.71K derived: sum of 3 quarters · filed 2013-03-28 | $3.60K 10-K · filed 2013-03-28 | $6.32K 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | $908.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.80K derived: sum of 2 quarters · filed 2012-11-14 | $2.69K 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-06-30 | $897.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.78K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | $888.00 10-Q · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $1.89K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |